Litcius/Paper detail

Fluorescent ligands for dopamine D2/D3 receptors

Anni Allikalt, Nirupam Purkayastha, Khajidmaa Flad, Maximilian F. Schmidt, Alina Tabor, Peter Gmeiner, Harald Hübner, Dorothée Weikert

2020Scientific Reports27 citationsDOIOpen Access PDF

Abstract

Abstract Fluorescent ligands are versatile tools for the study of G protein-coupled receptors. Depending on the fluorophore, they can be used for a range of different applications, including fluorescence microscopy and bioluminescence or fluorescence resonance energy transfer (BRET or FRET) assays. Starting from phenylpiperazines and indanylamines, privileged scaffolds for dopamine D 2 -like receptors, we developed dansyl-labeled fluorescent ligands that are well accommodated in the binding pockets of D 2 and D 3 receptors. These receptors are the target proteins for the therapy for several neurologic and psychiatric disorders, including Parkinson’s disease and schizophrenia. The dansyl-labeled ligands exhibit binding affinities up to 0.44 nM and 0.29 nM at D 2 R and D 3 R, respectively. When the dansyl label was exchanged for sterically more demanding xanthene or cyanine dyes, fluorescent ligands 10a-c retained excellent binding properties and, as expected from their indanylamine pharmacophore, acted as agonists at D 2 R. While the Cy3B-labeled ligand 10b was used to visualize D 2 R and D 3 R on the surface of living cells by total internal reflection microscopy, ligand 10a comprising a rhodamine label showed excellent properties in a NanoBRET binding assay at D 3 R.

Topics & Concepts

Dopamine receptor D3ReceptorDopamineDopamine receptorFluorescenceDopamine receptor D2NeuroscienceChemistryBiologyBiochemistryPhysicsQuantum mechanicsReceptor Mechanisms and SignalingNeurotransmitter Receptor Influence on BehaviorPharmacological Receptor Mechanisms and Effects
Fluorescent ligands for dopamine D2/D3 receptors | Litcius